Cargando…
2371 Validation of a novel PD-L1 assay for bladder cancer circulating tumor cells
OBJECTIVES/SPECIFIC AIMS: Bladder cancer patients being considered for immune checkpoint blockade are often judged on immunohistochemical staining for the checkpoint target protein PD-L1 in the original surgery or biopsy sample. However, sampling error or the clinical evolution of most patients’ can...
Autores principales: | Seranio, Nicolas, Aguarin, Louise, Dorsey, Jay F., Christodouleas, John P., Kao, Gary D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798935/ http://dx.doi.org/10.1017/cts.2018.150 |
Ejemplares similares
-
2525 Development of human cell-based screening assays to detect subject-specific drug-response variability
por: Stillitano, Francesca, et al.
Publicado: (2018) -
2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
por: Florez-Pollack, Stephanie, et al.
Publicado: (2018) -
2421 Development and validation of a translational rat model of neonatal abstinence syndrome
por: Brents, Lisa, et al.
Publicado: (2018) -
3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs
por: Stillitano, Francesca, et al.
Publicado: (2019) -
2406 The microbial-derived short-chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation
por: Kibbie, Jon, et al.
Publicado: (2018)